AtriCure (ATRC) Shares Outstanding (2010 - 2026)
AtriCure (ATRC) posted quarterly Shares Outstanding (Entity) of $50.9 million for Q2 2026, up 2.36% year-over-year from $49.7 million in Q2 2025, and little changed quarter-over-quarter from $50.6 million in Q1 2026.
AtriCure (ATRC) Shares Outstanding (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Shares Outstanding (Entity) for 17 consecutive years, with $50.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 2.36% year-over-year to $50.9 million; the TTM figure through Jun 2026 stood at $50.9 million (up 2.36% YoY), while the FY2025 annual figure was $49.8 million, up 1.89% from the prior year.
- Shares Outstanding (Entity) was little changed at $50.9 million in Q2 2026 per ATRC's latest filing, from $50.6 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $50.9 million in Q2 2026 and bottomed at $46.3 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $48.3 million across 5 years, with a median of $48.5 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 1.11% — and 2024, when it gained 2.86%.
- AtriCure's Shares Outstanding (Entity) stood at $46.6 million in 2022, then gained by 2.07% to $47.5 million in 2023, then increased by 2.83% to $48.9 million in 2024, then climbed by 1.89% to $49.8 million in 2025, then increased by 2.15% to $50.9 million in 2026.
- Business Quant data shows ATRC's Shares Outstanding (Entity) at $50.9 million in Q2 2026, $50.6 million in Q1 2026, and $49.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 48.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.67 Mn |
| Mar 31, 2026 | 48.33 Mn |
| Dec 31, 2025 | 47.75 Mn |
| Sep 30, 2025 | 47.92 Mn |
| Jun 30, 2025 | 47.72 Mn |
| Mar 31, 2025 | 47.39 Mn |
| Dec 31, 2024 | 46.97 Mn |
| Sep 30, 2024 | 47.11 Mn |
| Jun 30, 2024 | 46.91 Mn |
| Mar 31, 2024 | 46.72 Mn |
| Dec 31, 2023 | 46.31 Mn |
| Sep 30, 2023 | 46.41 Mn |
| Jun 30, 2023 | 46.27 Mn |
| Mar 31, 2023 | 46.11 Mn |
| Dec 31, 2022 | 45.74 Mn |
| Sep 30, 2022 | 45.82 Mn |
| Jun 30, 2022 | 45.69 Mn |
| Mar 31, 2022 | 45.53 Mn |
| Dec 31, 2021 | 45.07 Mn |
| Sep 30, 2021 | 45.26 Mn |